E13Subgroup analysis of patients with metastatic colorectal...

Annals of Oncology 2015 / 10 Vol. 26; Iss. suppl 6

E13Subgroup analysis of patients with metastatic colorectal cancer (mCRC) treated with regorafenib (REG) in the CORRECT trial who had progression-free survival (PFS) longer than 4 months:

Sobrero, A., Grothey, A., Siena, S., Falcone, A., Ychou, M., Humblet, Y., Bouche, O., Mineur, L., Barone, C., Adenis, A., Tabernero, J., Yoshino, T., Lenz, H., Goldberg, R.M., Xu, L., Wagner, A., Van
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv340.13
Date:
October, 2015
File:
PDF, 43 KB
english, 2015
Conversion to is in progress
Conversion to is failed